Annual Accounts Receivable
$3.97 M
-$28.09 M-87.61%
December 31, 2024
Summary
- As of March 12, 2025, ARCT annual accounts receivable is $3.97 million, with the most recent change of -$28.09 million (-87.61%) on December 31, 2024.
- During the last 3 years, ARCT annual accounts receivable has risen by +$607.00 thousand (+18.03%).
- ARCT annual accounts receivable is now -87.61% below its all-time high of $32.06 million, reached on December 31, 2023.
Performance
ARCT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$3.97 M
-$26.23 M-86.84%
December 31, 2024
Summary
- As of March 12, 2025, ARCT quarterly accounts receivable is $3.97 million, with the most recent change of -$26.23 million (-86.84%) on December 31, 2024.
- Over the past year, ARCT quarterly accounts receivable has stayed the same.
- ARCT quarterly accounts receivable is now -95.70% below its all-time high of $92.48 million, reached on March 31, 2023.
Performance
ARCT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ARCT Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -87.6% | 0.0% |
| 3 y3 years | +18.0% | +94.4% |
| 5 y5 years | +82.4% | +94.4% |
ARCT Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -87.6% | +43.8% | -95.7% | +94.4% |
| 5 y | 5-year | -87.6% | +87.0% | -95.7% | +98.0% |
| alltime | all time | -87.6% | +727.9% | -95.7% | +727.9% |
Arcturus Therapeutics Holdings Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $3.97 M(-87.6%) | $3.97 M(-86.8%) |
| Sep 2024 | - | $30.20 M(+25.4%) |
| Jun 2024 | - | $24.09 M(-11.0%) |
| Mar 2024 | - | $27.06 M(-15.6%) |
| Dec 2023 | $32.06 M(+1060.1%) | $32.06 M(-16.1%) |
| Sep 2023 | - | $38.22 M(+1265.5%) |
| Jun 2023 | - | $2.80 M(-97.0%) |
| Mar 2023 | - | $92.48 M(+3246.0%) |
| Dec 2022 | $2.76 M(-17.9%) | $2.76 M(+35.2%) |
| Sep 2022 | - | $2.04 M(-9.0%) |
| Jun 2022 | - | $2.25 M(-39.1%) |
| Mar 2022 | - | $3.69 M(+9.6%) |
| Dec 2021 | $3.37 M | $3.37 M(+67.1%) |
| Sep 2021 | - | $2.02 M(-6.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $2.16 M(+7.8%) |
| Mar 2021 | - | $2.01 M(-5.6%) |
| Dec 2020 | $2.13 M(-2.5%) | $2.13 M(-13.2%) |
| Sep 2020 | - | $2.45 M(-13.5%) |
| Jun 2020 | - | $2.83 M(+20.3%) |
| Mar 2020 | - | $2.35 M(+7.9%) |
| Dec 2019 | $2.18 M(-51.4%) | $2.18 M(-17.0%) |
| Sep 2019 | - | $2.63 M(-54.9%) |
| Jun 2019 | - | $5.82 M(+30.5%) |
| Mar 2019 | - | $4.46 M(-0.5%) |
| Dec 2018 | $4.48 M(+833.5%) | $4.48 M(+299.0%) |
| Sep 2018 | - | $1.12 M(-18.1%) |
| Jun 2018 | - | $1.37 M(+185.6%) |
| Dec 2017 | $480.00 K(-86.8%) | $480.00 K(-86.8%) |
| Dec 2016 | $3.63 M | $3.63 M |
FAQ
- What is Arcturus Therapeutics Holdings annual accounts receivable?
- What is the all time high annual accounts receivable for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual accounts receivable year-on-year change?
- What is Arcturus Therapeutics Holdings quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings quarterly accounts receivable year-on-year change?
What is Arcturus Therapeutics Holdings annual accounts receivable?
The current annual accounts receivable of ARCT is $3.97 M
What is the all time high annual accounts receivable for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual accounts receivable is $32.06 M
What is Arcturus Therapeutics Holdings annual accounts receivable year-on-year change?
Over the past year, ARCT annual accounts receivable has changed by -$28.09 M (-87.61%)
What is Arcturus Therapeutics Holdings quarterly accounts receivable?
The current quarterly accounts receivable of ARCT is $3.97 M
What is the all time high quarterly accounts receivable for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly accounts receivable is $92.48 M
What is Arcturus Therapeutics Holdings quarterly accounts receivable year-on-year change?
Over the past year, ARCT quarterly accounts receivable has changed by $0.00 (0.00%)